SCHEMBL7800835

SCHEMBL7800835

CCOC(=O)c1c(Oc2ccc3c(c2)OCO3)cccc1Oc1ccc(OC)cc1/C=C/C(=O)OC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.47
KDM4E B2RXH2 9/20 0.47
HPGD P15428 6/20 0.47
LMNA P02545 6/20 0.47
GAA P10253 3/20 0.47
MAPT P10636 10/20 0.44
GLA P06280 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
NPC1 O15118 5/20 0.44
RAB9A P51151 5/20 0.44
SMN1; SMN2 Q16637 4/20 0.44
POLB P06746 3/20 0.44
MAPK1 P28482 1/20 0.42
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.41
CYP1A2 P05177 2/20 0.41
CYP3A4 P08684 2/20 0.41
CYP2C9 P11712 2/20 0.41
CYP2C19 P33261 2/20 0.41
CYP2D6 P10635 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7791768 1.00 ALDH1A1 (0.47) ALDH1A1KDM4EHPGDLMNAGAA
SCHEMBL7791682 0.91 MAPT (0.42) ALDH1A1KDM4EHPGDLMNAGAA
SCHEMBL7791680 0.91 MAPT (0.42) ALDH1A1KDM4EHPGDLMNAGAA
SCHEMBL8541779 0.89 KDM4E (0.47) ALDH1A1KDM4EHPGDLMNAGAA
SCHEMBL7799669 0.89 MAPT (0.46) ALDH1A1KDM4EHPGDLMNAMAPT
SCHEMBL8541775 0.89 KDM4E (0.47) ALDH1A1KDM4EHPGDLMNAGAA
SCHEMBL7799781 0.84 RAB9A (0.50) ALDH1A1HPGDMAPTL3MBTL1NPC1
SCHEMBL7800988 0.83 MAPT (0.50) ALDH1A1HPGDMAPTL3MBTL1NPC1
SCHEMBL7791673 0.83 LMNA (0.42) ALDH1A1KDM4EHPGDLMNAMAPT
SCHEMBL7791674 0.83 LMNA (0.42) ALDH1A1KDM4EHPGDLMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010014694-A1 Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin ENCYSIVE PHARMACEUTICALS, INC. 2001-08-16 US disclosed
US-6265428-B1 VASODILATION TEXAS BIOTECHNOLOGY CORPORATION 2001-07-24 US disclosed
US-5977117-A Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin TEXAS BIOTECHNOLOGY CORPORATION (US) 1999-11-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010014694-A1 Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin EDNRA, EDNRB, NPR1 ALDH1A1 4421/4885KDM4E 1955/4885HPGD 1273/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.